The consumer genetics company reported full-year revenue came to $272 million, an 11% increase compared with the prior year.
23andMe posts $217M net loss during ‘transitional’ fiscal year
The consumer genetics company reported full-year revenue came to $272 million, an 11% increase compared with the prior year.
